Abstract
Introduction Mid-regional pro-atrial natriuretic peptide (MR-proANP), procalcitonin (PCT), and mid-regional pro-adrenomedullin (MR-proADM) demonstrated usefulness for management of emergency department patients with dyspnea. Methods To evaluate in patients with dyspnea, the prognostic value for 30 and 90 days mortality and readmission of PCT, MR-proADM, and MR-proANP, a multicenter prospective study was performed evaluating biomarkers at admission, 24 and 72 hours after admission. Based on final diagnosis, patients were divided into acute heart failure (AHF), primary lung diseases, or both (AHF + NO AHF). Results Five hundred one patients were enrolled. Procalcitonin and MR-proADM values at admission and at 72 hours were significantly (P
| Original language | English |
|---|---|
| Pages (from-to) | 334-341 |
| Number of pages | 8 |
| Journal | American Journal of Emergency Medicine |
| Volume | 32 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2014 |
Fingerprint
ASJC Scopus subject areas
- Emergency Medicine
Cite this
Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial. / Travaglino, Francesco; Russo, Veronica; De Berardinis, Benedetta; Numeroso, Filippo; Catania, Pamela; Cervellin, Gianfranco; Nigra, Stefano Geniere; Geraci, Francesco; Bressan, Maria Antonietta; Guerrini, Stefania; Cavazza, Mario; Folli, Christian; Monzani, Valter; Battista, Stefania; Mengozzi, Giulio; Noto, Paola; Carpinteri, Giuseppe; Semplicini, Andrea; Stella, Federica; Ingrassia, Stella; Moscatelli, Paolo; Giuntini, Patrizia; Salerno, Gerardo; Cardelli, Patrizia; Di Somma, Salvatore.
In: American Journal of Emergency Medicine, Vol. 32, No. 4, 2014, p. 334-341.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial
AU - Travaglino, Francesco
AU - Russo, Veronica
AU - De Berardinis, Benedetta
AU - Numeroso, Filippo
AU - Catania, Pamela
AU - Cervellin, Gianfranco
AU - Nigra, Stefano Geniere
AU - Geraci, Francesco
AU - Bressan, Maria Antonietta
AU - Guerrini, Stefania
AU - Cavazza, Mario
AU - Folli, Christian
AU - Monzani, Valter
AU - Battista, Stefania
AU - Mengozzi, Giulio
AU - Noto, Paola
AU - Carpinteri, Giuseppe
AU - Semplicini, Andrea
AU - Stella, Federica
AU - Ingrassia, Stella
AU - Moscatelli, Paolo
AU - Giuntini, Patrizia
AU - Salerno, Gerardo
AU - Cardelli, Patrizia
AU - Di Somma, Salvatore
PY - 2014
Y1 - 2014
N2 - Introduction Mid-regional pro-atrial natriuretic peptide (MR-proANP), procalcitonin (PCT), and mid-regional pro-adrenomedullin (MR-proADM) demonstrated usefulness for management of emergency department patients with dyspnea. Methods To evaluate in patients with dyspnea, the prognostic value for 30 and 90 days mortality and readmission of PCT, MR-proADM, and MR-proANP, a multicenter prospective study was performed evaluating biomarkers at admission, 24 and 72 hours after admission. Based on final diagnosis, patients were divided into acute heart failure (AHF), primary lung diseases, or both (AHF + NO AHF). Results Five hundred one patients were enrolled. Procalcitonin and MR-proADM values at admission and at 72 hours were significantly (P
AB - Introduction Mid-regional pro-atrial natriuretic peptide (MR-proANP), procalcitonin (PCT), and mid-regional pro-adrenomedullin (MR-proADM) demonstrated usefulness for management of emergency department patients with dyspnea. Methods To evaluate in patients with dyspnea, the prognostic value for 30 and 90 days mortality and readmission of PCT, MR-proADM, and MR-proANP, a multicenter prospective study was performed evaluating biomarkers at admission, 24 and 72 hours after admission. Based on final diagnosis, patients were divided into acute heart failure (AHF), primary lung diseases, or both (AHF + NO AHF). Results Five hundred one patients were enrolled. Procalcitonin and MR-proADM values at admission and at 72 hours were significantly (P
UR - http://www.scopus.com/inward/record.url?scp=84897456489&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84897456489&partnerID=8YFLogxK
U2 - 10.1016/j.ajem.2013.12.045
DO - 10.1016/j.ajem.2013.12.045
M3 - Article
VL - 32
SP - 334
EP - 341
JO - American Journal of Emergency Medicine
JF - American Journal of Emergency Medicine
SN - 0735-6757
IS - 4
ER -